Create Free Account

By creating account you will get access to hot stocks & personalised emails

Cleanspace Holdings Ltd

Healthcare AU CSX

0.465AUD
0.005(1.09%)

Last update at 2024-09-16T05:16:00Z

Day Range

0.460.47
LowHigh

52 Week Range

0.220.64
LowHigh

Fundamentals

  • Previous Close 0.46
  • Market Cap37.42M
  • Volume1168
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-4.33232M
  • Revenue TTM15.72M
  • Revenue Per Share TTM0.20
  • Gross Profit TTM 8.41M
  • Diluted EPS TTM-0.04

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -11.82657M -15.27697M 15.96M 7.28M -1.06429M
Minority interest - - - - -
Net income -8.13159M -11.28144M 11.39M 5.92M -1.06429M
Selling general administrative 18.45M 17.14M 16.02M 12.44M 8.48M
Selling and marketing expenses - 4.05M 3.68M - -
Gross profit 8.41M 9.75M 40.27M 21.03M 7.51M
Reconciled depreciation 1.04M 1.02M 1.13M - -
Ebit -11.83134M -15.13143M 16.01M 7.32M -1.07371M
Ebitda -10.62730M -14.11498M 17.15M - -
Depreciation and amortization - 1.02M 1.13M - -
Non operating income net other - - - - -
Operating income -11.81980M -15.13143M 16.01M 6.41M -2.22293M
Other operating expenses - 28.48M 34.01M -0.97592M 0.90M
Interest expense 0.16M 0.16M 0.00822M 0.00000M 0.00000M
Tax provision -3.69498M -3.99553M 4.57M 1.36M 0.00000M
Interest income 0.00677M 0.06M 0.07M 0.04M 0.00942M
Net interest income -0.00677M -0.20684M -0.06874M - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -3.69498M -3.99553M 4.57M 1.36M -
Total revenue 12.09M 13.36M 49.93M 28.40M 11.06M
Total operating expenses - 24.87M 24.35M - -
Cost of revenue 3.69M 3.61M 9.66M 7.37M 3.55M
Total other income expense net 0.00905M 0.05M 0.11M - -
Discontinued operations - - - - -
Net income from continuing ops -8.13159M -11.28144M 11.39M - -
Net income applicable to common shares -8.13159M -11.28144M 11.39M 5.92M -1.06429M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 26.05M 28.98M 38.36M 50.72M 49.80M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.41M 1.24M 3.48M 0.48M 3.80M
Total liab 6.95M 7.02M 8.60M 9.99M 10.40M
Total stockholder equity 19.10M 21.96M 29.75M 40.73M 39.40M
Deferred long term liab - - - - -
Other current liab 2.57M 1.55M 3.41M 4.34M 3.50M
Common stock 33.55M 33.44M 33.43M 33.43M 33.70M
Capital stock - 33.44M 33.43M 33.43M 33.70M
Retained earnings -15.17476M -12.23304M -4.15700M 6.76M 5.30M
Other liab - 0.36M 0.42M 0.47M 0.20M
Good will - - - - -
Other assets 0.00000M 6.31M 0.90M 1.06M 0.92M
Cash 2.75M 3.12M 8.22M 22.21M 31.00M
Cash and equivalents - - - - -
Total current liabilities 3.76M 3.30M 7.02M 7.92M 8.30M
Current deferred revenue 0.04M - - 4.33M 2.50M
Net debt 0.70M - -4.09396M -17.82448M -28.60000M
Short term debt 0.53M 0.00000M 2.97M 2.78M 0.50M
Short long term debt - 0.15M 2.53M 2.37M -
Short long term debt total 3.45M - 4.13M 4.38M 2.40M
Other stockholder equity - 0.75M 0.48M 0.53M 0.58M
Property plant equipment - 2.40M 3.44M 3.85M 1.01M
Total current assets 17.64M 20.26M 33.99M 45.77M 45.40M
Long term investments - - - - -
Net tangible assets - 21.95M 29.73M 40.69M 6.73M
Short term investments 7.02M 9.04M 16.08M 16.03M 3.58M
Net receivables 4.59M 3.32M 2.47M 2.44M 8.80M
Long term debt - 2.68M - 0.00293M 2.34M
Inventory 2.87M 2.99M 3.74M 4.61M 1.80M
Accounts payable 0.62M 0.26M 0.64M 0.80M 4.30M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.73M - 0.48M 0.53M 0.40M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -0.00000M - - - -
Deferred long term asset charges - - - - -
Non current assets total 8.41M 8.72M 4.36M 4.95M 4.40M
Capital lease obligations - 1.16M 1.60M 2.01M 2.40M
Long term debt total - 3.36M 1.16M 1.60M 2.35M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 7.04M -0.04374M -12.45809M -1.54180M -1.40527M
Change to liabilities -4.02448M 0.48M -2.75069M 3.31M 0.47M
Total cashflows from investing activities 7.06M -0.62800M -14.18492M -1.94145M -1.50070M
Net borrowings -0.21149M -0.35795M -2.89190M 2.17M -0.00269M
Total cash from financing activities -0.21149M -0.35795M 16.19M 2.17M -0.00269M
Change to operating activities 0.07M -0.11553M 0.35M 0.36M 0.17M
Net income -8.13159M -11.28144M 11.39M 5.92M -1.06429M
Change in cash -5.10887M -13.98243M 15.46M 4.94M -2.44551M
Begin period cash flow 8.22M 22.21M 6.74M - -
End period cash flow 3.12M 8.22M 22.21M 6.74M -
Total cash from operating activities -11.96072M -12.99648M 13.46M 4.71M -0.94212M
Issuance of capital stock - - 19.08M - -
Depreciation 1.02M 1.00M 1.11M 0.43M 0.24M
Other cashflows from investing activities 7.07M -0.02217M -12.45809M -1.54180M -1.40527M
Dividends paid - - - - -
Change to inventory 0.75M 0.72M -3.49503M -1.00401M -0.15423M
Change to account receivables -0.95223M -0.01281M 6.21M -6.59194M -0.67769M
Sale purchase of stock - 0.00000M 19.08M - -
Other cashflows from financing activities - -0.62800M -0.55492M - -
Change to netincome 0.41M 0.54M 1.27M 0.16M 0.07M
Capital expenditures 0.00526M 0.61M 1.73M 0.40M 0.10M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.08M -0.10080M -5.36747M 0.06M 0.08M
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow -11.96598M -0.60583M -1.72683M - -

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CSX
Cleanspace Holdings Ltd		 0.005 1.09% 0.47 - - 2.38 1.83 2.08 -1.5294
COH
Cochlear Ltd		 -0.73 0.25% 290.07 53.58 44.84 8.52 10.18 8.26 31.89
PNV
Polynovo Ltd		 -0.13 5.04% 2.45 253.50 169.49 17.00 24.32 16.70 425.94
AVH
Avita Therapeutics Inc		 0.23 8.21% 3.03 - - 6.90 10.06 4.35 -10.0538
EBR
Ebr Systems Inc CDR		 -0.035 3.68% 0.92 - - - 18.30 - -3.6785

Reports Covered

Stock Research & News

View All

Profile

CleanSpace Holdings Limited engages in the design, manufacture, and sale of respiratory protection products and services for healthcare and industrial markets worldwide. It offers CleanSpace HALO, an elevated level of respiratory protection in healthcare environment; CleanSpace CST PRO, a technology that keeps protected and connected; CleanSpace CST ULTRA, a powered air purifying respirator (PAPR) that provides protection reporting for enhanced safety compliance; CleanSpace EX, an PAPR for explosive atmospheres; and CleanSpace Work, an industrial PAPR for high dust environments. The company also provides accessories and consumable products comprising masks, filters, and docking stations. CleanSpace Holdings Limited was founded in 2009 and is based in St Leonards, Australia.

Cleanspace Holdings Ltd

Unit 5, St Leonards, NSW, Australia, 2065

Key Executives

Name Title Year Born
Dr. Alexandra Birrell CEO & Exec. Director NA
Ms. Elizabeth Harvey CFO & Joint Company Sec. NA
Mr. Dan Kao Director of Operations & Exec. Director NA
Mr. Alex Virr Chief Technology Officer NA
Mr. Jon Imms Global Sales Director NA
Ms. Elissa Hansen Joint Company Sec. NA
Mr. Graham A. McLean CPA, CIMA CEO & Director 1965
Mr. Dan Kao Director of Innovation & Operations and Executive Director NA
Ms. Bree Greeff Interim Chief Financial Officer NA
Mr. Graham A. McLean CPA, CIMA CEO & Director 1965

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.